Database Lock to DSMB Meeting Pushing a button well takes 2-4 weeks

Slides:



Advertisements
Similar presentations
FDA/Industry Workshop September, 19, 2003 Johnson & Johnson Pharmaceutical Research and Development L.L.C. 1 Uses and Abuses of (Adaptive) Randomization:
Advertisements

Phase II/III Design: Case Study
A Coherent and Practical End-to-End Metadata Strategy using Existing Standards and Tools for Clinical Research Stephane AUGER Danone Research, FRANCE.
The Importance of CDASH
ESource: Unlocking the Efficiencies of Electronic Source Data Capture Ed Seguine, CEO, Clinical Ink April 15, 2014.
Kendle Implementation of Clinical Data Acquisition Standards Harmonization Dr Elke Sennewald Kendle 9th German CDISC User Group Meeting Berlin, 28 September.
Copyright © 2013, SAS Institute Inc. All rights reserved. LEVERAGE THE CDISC DATA MODEL TO STREAMLINE ANALYTICAL WORKFLOWS KELCI J. MICLAUS, PH.D. RESEARCH.
CONFIDENTIAL Integration of SDTM File Creation into Study Analysis: A Practical Approach Anna Kunina, Edzel Cabanero, Efim Dynin, Lindley Frahm 04Apr2008.
From Data Capture to Decisions Making Innovation through Standardization How Can Standardization Help Innovation Michaela Jahn, Stephan Laage-Witt PHUSE.
Security in Databases. 2 Srini & Nandita (CSE2500)DB Security Outline review of databases reliability & integrity protection of sensitive data protection.
Security in Databases. 2 Outline review of databases reliability & integrity protection of sensitive data protection against inference multi-level security.
Using EDC-Rave to Conduct Clinical Trials at Genentech
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems.
CDISC and how Stata can help us implement it
23 August 2015Michael Knoessl1 PhUSE 2008 Manchester / Michael Knoessl Implementing CDISC at Boehringer Ingelheim.
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data.
Implementation of a harmonized, report-friendly SDTM and ADaM Data Flow General by Marie-Rose Peltier Experience by Marie Fournier Groupe Utilisateurs.
ODM-SDTM mapping Nicolas de Saint Jorre, XClinical June 20, 2008 French CDISC User Group Bagneux/Paris © CDISC & XClinical, 2008.
New Role Models for the EDC Study Team Training, workflow and service provision DTI Conference Centre 1 st November 2005 Emma Banks Datatrial Limited.
BIOTECH SUPPLY October 8-9, 2012 Crowne Plaza, Foster City, CA Solving the Missing Link Between Forecasting and ERP in Clinical Supply Optimization Michelle.
Data Management in Clinical Trials. E-CRF design / P-CRF Data entryData validation Data import Clinical coding DATABASE CLOSURE Database Closure Documents.
Alun, living with Parkinson’s disease QS Domain: Challenges and Pitfalls Knut Müller UCB Biosciences Conference 2011 October 9th - 12th, Brighton UK.
Driving value through Standardization – Industry Challenges and Best Practices Henry Levy, partner-Life Sciences R&D European Lead.
SAE data entry: Clinical versus Pharmacovigilance standards Daniel Becker Solvay Pharmaceuticals Hannover, Germany T:
Using EDC-Rave to Conduct Clinical Trials at Genentech Susanne Prokscha Principal CDM PTM Process Analyst February 2012.
Identifying and recruiting patients for clinical trials in the future: a pharma perspective Rob Thwaites EC/EFPIA Workshop on ” Primary and secondary use.
24 Nov 2007Data Management and Exploratory Data Analysis 1 Yongyuth Chaiyapong Ph.D. (Mathematical Statistics) Department of Statistics Faculty of Science.
How Good is Your SDTM Data? Perspectives from JumpStart Mary Doi, M.D., M.S. Office of Computational Science Office of Translational Sciences Center for.
ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC Joerg Guettner, Lead Statistical Analyst, Bayer Pharma, Wuppertal,
End-to-End With Standards – A Regulatory Reviewer’s Perspective
Data Management in Clinical Research
Modeling and Simulation CS 313
Data Standards for Pharmacometric Analysis Data Sets
Improvements in editing methods and processes for use of Value Added Tax data in UK National Accounts Martina Portanti and Robert Breton Office for National.
CLINICAL PROTOCOL DEVELOPMENT
Auditing Information Technology
Chapter 18 Maintaining Information Systems
Modeling and Simulation CS 313
EHR Integration Making Research Efficient
The ILC Control Work Packages
Software Processes (a)
Hypothesis Testing and Confidence Intervals (Part 1): Using the Standard Normal Lecture 8 Justin Kern October 10 and 12, 2017.
Why use CDISC for trials not submitted to regulators?
MAKE SDTM EASIER START WITH CDASH !
Strategies for Implementing Flexible Clinical Trials Jerald S. Schindler, Dr.P.H. Cytel Pharmaceutical Research Services 2006 FDA/Industry Statistics Workshop.
Creating ADaM Friendly Analysis Data from SDTM Using Meta-data by Erik Brun & Rico Schiller (CD ) H. Lundbeck A/S 13-Oct
Content & the Supply Chain
Traceability between SDTM and ADaM converted analysis datasets
The IAASB’s Future Strategy
Freundschaft Konferenz
2018 NM Community Survey Data Entry Training
Experiment Basics: Designs
Tools of Software Development
Patterns emerging from chaos
Myeloma UK Clinical Trial Network (CTN)
Larix – a full service Clinical Research Organisation
Fabienne NOEL CDISC – 2013, December 18th
The DMC’s role in monitoring futility
Data Monitoring committees and adaptive decision-making
Carolina Mendoza-Puccini, MD
Project Risk Analysis and Management: L3
Data Management in Support of A Clinical Event Committee (CEC)
Welcome Traceability Software Integrators
Presenters Emily Woolley
Discrepancy Management
Indicator 3.05 Interpret marketing information to test hypotheses and/or to resolve issues.
Serious Adverse Event Reconciliation
11/23/2019 Database lock to Data Safety Monitoring Board meeting – More than a click of a button David Prince, PhD, Manager, Biostatistics
Natasa Rajicic, ScD July 31, 2019
Database Lock to DMC meeting
Presentation transcript:

Database Lock to DSMB Meeting Pushing a button well takes 2-4 weeks Kevin A. Buhr Director, University of Wisconsin Statistical Data Analysis Center

Our Group University of Wisconsin Statistical Data Analysis Center (SDAC) Independent statistical support for DMC-monitored industry trials (mostly Phase 3) Variety of large (programs w/ 5-15 trials; large CV trials with ~10000 subjects) and small projects (n=30, 2-week intervention in orphan disease)

DMC Requirements The DMC wants a report that is: Current Correct Complete Comprehensible Customizable to evolving requirements No single requirement dominates all the others; they all are important.

Importance of Data Currency Recent, typical project: Two Phase 3 trials, 4-5 years, n=11000 DMC teleconference 2-3 times per year DMC report distributed one week in advance Delay from data transfer to DMC TC Range 2.5-7.5 weeks, median 3.5 weeks Report delivered one week before TC

Importance of Data Currency Typical evolution of a potential safety signal (or, in this case, “non-signal”), as actually reported: Note: results simulated based on actual distribution.

Importance of Data Currency Theoretical “perfect” reporting: All events captured on date of occurrence Snapshot/report generated day of DMC meeting DMC happy to review in an hour or two So, “unattainable”

Data Currency in Perspective Comparison of actual and “perfect” data:

Data Currency in Perspective Early in trial Signal is sensitive to additional data Signal is also sensitive to sampling error and random noise Degree of uncertainty is very high Later in trial Signal has stabilized Even in context of ongoing rapid enrollment, 3-5 weeks worth of additional data will rarely materially change results This doesn’t mean data currency is unimportant, but that it can and should be balanced against other requirements.

EDC Effect on SDAC Workflow Currency of data has little effect on SDAC workflow Before and after EDC, we received SAS snapshots Improved data quality doesn’t materially increase our efficiency Defensive programming Validation Isn’t particularly easier w/ 5 errors versus 500 errors

CDISC for Interim Reporting Problems solved by SDTM were never serious bottlenecks in our workflow: Standardizing names and formats for variables Specification of trial metadata (epochs, etc.) Adapting existing analysis code to new project These are “fixed cost” (and generally low cost) items for interim reporting

What Does Speed the Process? In our experience, we’ve had good luck with: Regular, frequently, as-is data transfers (e.g., monthly) A strong build system (e.g., draft reports for multi-protocol projects built within hours of new data transfer) An agile, continuous integration workflow Statistician-programmers with soup-to-nuts responsibility for blocks of content Nonetheless, we consider a reasonable snapshot-to-distribution timeline to be measured in weeks, not days.

Backup

EDC Effect on Overall Process Compared to days of paper CRFs: Data are far more current/up-to-date EDC eliminates many classes of errors, though introduces some new ones EDC streamlines query resolution process Facilitates frequent, as-is snapshots Large net positive effect on data currency and quality

CDISC for Interim Reporting CDISC SDTM is mixture of: Extreme inflexibility (no extra variables allowed) Extreme flexibility (FA domain, SUPP* domains, RELREC mechanisms) Compared to a direct mapping of eCRF to a “raw” dataset, SDTM: Obscures traceability (particularly if mapping contains some errors or relies on perfectly clean data) Obscures investigator “intention” where data are inconsistent We may waste time “unmapping” SDTM to original form Often, SDTMs often not ready early enough May need to start with raw and switch to SDTM

SDAC Workflow Receipt of new data Data checking / dataset exploration Data preprocessing Analysis dataset creation Graphical and tabular presentation Report compilation Quality assurance

Programming Ahead vs. Behind In our experience, report programming is an ongoing process: